Cas 1105054-49-6,(2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyrrole 1-oxide

1105054-49-6

Post Buying Request

Basic information

Product Name: (2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyrrole 1-oxide
Synonyms: (2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyrrole 1-oxide
CAS NO:1105054-49-6
Molecular Formula:
Molecular Weight: 417.505
EINECS: N/A
Product Categories: N/A
Mol File: 1105054-49-6.mol
Article Data: 6

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyrrole 1-oxide(CAS DataBase Reference)
NIST Chemistry Reference: (2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyrrole 1-oxide(1105054-49-6)
EPA Substance Registry System: (2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyrrole 1-oxide(1105054-49-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1105054-49-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1105054-49-6 Suppliers

Recommended suppliersmore

1105054-49-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1105054-49-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,5,0,5 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1105054-49:
(9*1)+(8*1)+(7*0)+(6*5)+(5*0)+(4*5)+(3*4)+(2*4)+(1*9)=96
96 % 10 = 6
So 1105054-49-6 is a valid CAS Registry Number.

1105054-49-6Upstream product

16838-89-4 2,3,5-tri-O-benzyl-α-L-ribofuranose

1105054-49-6Downstream Products

100937-51-7 (2R,3S,4R)-2-(hydroxymethyl)pyrrolidine-3,4-diol

1105054-49-6Relevant articles and documents

Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency

Cheng, Wei-Chieh,Wang, Jen-Hon,Li, Huang-Yi,Lu, Sheng-Jhih,Hu, Jia-Ming,Yun, Wen-Yi,Chiu, Cheng-Hsin,Yang, Wen-Bin,Chien, Yin-Hsiu,Hwu, Wuh-Liang

, p. 14 - 20 (2016)

A unique molecular library consisting of all sixteen synthetic ADMDP (1-aminodeoxy-DMDP) stereoisomers has been prepared and evaluated for inhibitory activity against α-Gal A, and ability to impart thermal stabilization of this enzyme. The results of this

Small structure tree alkali compound and its preparation method and application

-

Paragraph 0138; 0141; 0146; 0147; 0148, (2018/04/26)

The invention relates to a Broussonetia kazinoki alkaline compound. Structure of the compound is shown as a formula (1). The invention further provides a preparation method of the compound, a glycosidase inhibitor by using the compound or the compound prepared by the method as an active ingredient and application of the compound or the compound, prepared by the method, serving as an active ingredient in preparing drug. The Broussonetia kazinoki alkaline compound has high glycosidase inhibiting activity and potential medicinal value.

TREATMENT OF FABRY DISEASE

-

Paragraph 0105; 0107; 0108; 0141; 0142, (2018/04/11)

Disclosed herein are novel uses of a polyhydroxylated pyrrolidine for the manufacture of a medicament for treating Fabry disease (FD). Accordingly, the present disclosure provides a method of treating a subject having or suspected of having FD. The method

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1105054-49-6